B: Can be satisfactory. Either animal research show no danger but human studies not available or animal experiments showed insignificant pitfalls and human reports carried out and showed no risk.pentobarbital will decrease the level or impact of alosetron by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Small/Importance Not known.Reserve